Showing 1 - 7 results of 7 for search 'Melinda G Hollingshead', query time: 0.03s Refine Results
  1. 1
    DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors

    DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors by Angelo B. A. Laranjeira, Melinda G. Hollingshead, Dat Nguyen, Robert J. Kinders, James H. Doroshow, Sherry X. Yang

    Published 2023-04-01
    Get full text
    Article
  2. 2
    A spontaneously metastatic model of bladder cancer: imaging characterization

    A spontaneously metastatic model of bladder cancer: imaging characterization by James L. Tatum, Joseph D. Kalen, Paula M. Jacobs, Lilia V. Ileva, Lisa A. Riffle, Melinda G. Hollingshead, James H. Doroshow

    Published 2019-12-01
    Get full text
    Article
  3. 3
    A small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of concept.

    A small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of concept. by Susan D Mertins, Dominic A Scudiero, Melinda G Hollingshead, Raymond D Divelbiss, Michael C Alley, Anne Monks, David G Covell, Karen M Hite, David S Salomon, John E Niederhuber

    Published 2013-01-01
    Get full text
    Article
  4. 4
    3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumor

    3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tum... by James L. Tatum, Joseph D. Kalen, Paula M. Jacobs, Lisa A. Riffle, Amy James, Lai Thang, Chelsea Sanders, Melinda G. Hollingshead, Falguni Basuli, Jianfeng Shi, James H. Doroshow

    Published 2022-08-01
    Get full text
    Article
  5. 5
    Correction: Identification of CBX3 and ABCA5 as Putative Biomarkers for Tumor Stem Cells in Osteosarcoma.

    Correction: Identification of CBX3 and ABCA5 as Putative Biomarkers for Tumor Stem Cells in Osteosarcoma. by Vaibhav Saini, Curtis D. Hose, Anne Monks, Kunio Nagashima, Bingnan Han, Dianne L. Newton, Angelena Millione, Jalpa Shah, Melinda G. Hollingshead, Karen M. Hite, Mark W. Burkett, Rene M. Delosh, Thomas E. Silvers, Dominic A. Scudiero, Robert H. Shoemaker

    Published 2012-01-01
    Get full text
    Article
  6. 6
    Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma.

    Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma. by Vaibhav Saini, Curtis D Hose, Anne Monks, Kunio Nagashima, Bingnan Han, Dianne L Newton, Angelena Millione, Jalpa Shah, Melinda G Hollingshead, Karen M Hite, Mark W Burkett, Rene M Delosh, Thomas E Silvers, Dominic A Scudiero, Robert H Shoemaker

    Published 2012-01-01
    Get full text
    Article
  7. 7
    Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.

    Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. by Tony Navas, Thomas D Pfister, Simona Colantonio, Amina Aziz, Lynda Dieckman, Richard G Saul, Jan Kaczmarczyk, Suzanne Borgel, Sergio Y Alcoser, Melinda G Hollingshead, Young H Lee, Donald P Bottaro, Tara Hiltke, Gordon Whiteley, Naoko Takebe, Robert J Kinders, Ralph E Parchment, Joseph E Tomaszewski, James H Doroshow

    Published 2018-01-01
    Get full text
    Article

Search Tools: